The relationship between brain tumor cell invasion of engineered neural tissues and invivo features of glioblastoma

Biomaterials

Volumn 34, Issue 33, 2013, Pages 8279-8290

  Nayernia, Zeynab ^a   Turchi, Laurent ^c,d   Cosset, Erika ^b   Peterson, Hedi ^a   Dutoit, Valérie ^b   Dietrich, Pierre Yves ^b   Tirefort, Diderik ^a,b   Chneiweiss, Hervé ^c   Lobrinus, Johannes Alexander ^b   Krause, Karl Heinz ^a   Virolle, Thierry ^c,d   Preynat Seauve, Olivier ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c INSERM   (France)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Invitro test; Nerve tissue engineering; Neural cell; Stem cell

Indexed keywords

GLIOBLASTOMA CELLS; IN-VITRO TESTS; MOLECULAR ANALYSIS; NERVE TISSUE ENGINEERING; NEURAL CELLS; PLURIPOTENT STEM CELLS; TISSUE INTERACTIONS; TYPE I INTERFERONS;

BRAIN; CELL DEATH; GENES; STEM CELLS; TISSUE;

TISSUE ENGINEERING;

INTERFERON;

ANIMAL CELL; ARTICLE; BRAIN TISSUE; BRAIN TUMOR; CANCER PATIENT; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENGINEERED NEURAL TISSUE; GENE EXPRESSION; GENE IDENTIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; NERVOUS TISSUE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SURVIVAL RATE; TISSUE ENGINEERING; TUMOR CELL; TUMOR CELL LINE; TUMOR VOLUME;

IN VITRO TEST; NERVE TISSUE ENGINEERING; NEURAL CELL; STEM CELL;

ANIMALS; BRAIN NEOPLASMS; CELL LINE; CELLS, CULTURED; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; POLYMERASE CHAIN REACTION; PREGNANCY; STEM CELLS; TISSUE ENGINEERING;

EID: 84881664356     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.006     Document Type: Article

References (28)

1. Dunn G.P., Rinne M.L., Wykosky J., Genovese G., Quayle S.N., Dunn I.F., et al. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev 2012, 26:756-784.
2. Huszthy P.C., Daphu I., Niclou S.P., Stieber D., Nigro J.M., Sakariassen P.O., et al. Invivo models of primary brain tumors: pitfalls and perspectives. Neuro Oncol 2012, 14:979-993.
3. Binda E., Visioli A., Reynolds B., Vescovi A.L. Heterogeneity of cancer-initiating cells within glioblastoma. Front Biosci (Schol Ed) 2012, 4:1235-1248.
4. Das S., Srikanth M., Kessler J.A. Cancer stem cells and glioma. Nat Clin Pract Neurol 2008, 4:427-435.
5. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
6. Guerrero-Cazares H., Chaichana K.L., Quinones-Hinojosa A. Neurosphere culture and human organotypic model to evaluate brain tumor stem cells. Methods Mol Biol 2009, 568:73-83.
7. Ohnishi T., Matsumura H., Izumoto S., Hiraga S., Hayakawa T. Anovel model of glioma cell invasion using organotypic brain slice culture. Cancer Res 1998, 58:2935-2940.
8. Brehar F.M., Ciurea A.V., Chivu M., Zarnescu O., Radulescu R., Dragu D. The development of xenograft glioblastoma implants in nude mice brain. JMed Life 2008, 1:275-286.
9. Preynat-Seauve O., Suter D.M., Tirefort D., Turchi L., Virolle T., Chneiweiss H., et al. Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture. Stem Cells 2009, 27:509-520.
10. Suter D.M., Preynat-Seauve O., Tirefort D., Feki A., Krause K.H. Phenazopyridine induces and synchronizes neuronal differentiation of embryonic stem cells. JCell Mol Med 2009, 13:3517-3527.
11. Goplen D., Bougnaud S., Rajcevic U., Boe S.O., Skaftnesmo K.O., Voges J., et al. AlphaB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells. Am J Pathol 2010, 177:1618-1628.
12. Kim J.H., Bae Kim Y., Han J.H., Cho K.G., Kim S.H., Sheen S.S., et al. Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases. Am J Surg Pathol 2012, 36:620-628.
13. Cheon H., Stark G.R. Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc Natl Acad Sci U S A 2009, 106:9373-9378.
14. Reimand J., Kull M., Peterson H., Hansen J., Vilo J. g:Profiler - a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res 2007, 35:W193-W200.
15. Duarte C.W., Willey C.D., Zhi D., Cui X., Harris J.J., Vaughan L.K., et al. Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner. PLoS One 2012, 7:e29653.
16. Khodarev N.N., Beckett M., Labay E., Darga T., Roizman B., Weichselbaum R.R. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci U S A 2004, 101:1714-1719.
17. Tsai M.H., Cook J.A., Chandramouli G.V., DeGraff W., Yan H., Zhao S., et al. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res 2007, 67:3845-3852.
18. Haybaeck J., Obrist P., Schindler C.U., Spizzo G., Doppler W. STAT-1 expression inhuman glioblastoma and peritumoral tissue. Anticancer Res 2007, 27:3829-3835.
19. Sgorbissa A., Tomasella A., Potu H., Manini I., Brancolini C. Type I IFNs signaling and apoptosis resistance in glioblastoma cells. Apoptosis 2011, 16:1229-1244.
20. Gladson C.L. The extracellular matrix of gliomas: modulation of cell function. JNeuropathol Exp Neurol 1999, 58:1029-1040.
21. Rubenstein B.M., Kaufman L.J. The role of extracellular matrix in glioma invasion: a cellular Potts model approach. Biophys J 2008, 95:5661-5680.
22. Aguilar L.K., Arvizu M., Aguilar-Cordova E., Chiocca E.A. The spectrum of vaccine therapies for patients with glioblastoma multiforme. Curr Treat Options Oncol 2012, 13:437-450.
23. Gatson N.N., Chiocca E.A., Kaur B. Anti-angiogenic gene therapy in the treatment of malignant gliomas. Neurosci Lett 2012, 527:62-70.
24. Priester M., Copanaki E., Vafaizadeh V., Hensel S., Bernreuther C., Glatzel M., et al. STAT3 silencing inhibits glioma single cell infiltration and tumor growth. Neuro Oncol 2013, 15:840-852.
25. Guo D., Reinitz F., Youssef M., Hong C., Nathanson D., Akhavan D., et al. An LXR agonist promotes glioblastoma cell death through inhibition of anEGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov 2011, 1:442-456.
26. Rios-Marco P., Martin-Fernandez M., Soria-Bretones I., Rios A., Carrasco M.P., Marco C. Alkylphospholipids deregulate cholesterol metabolism and induce cell-cycle arrest and autophagy in U-87 MG glioblastoma cells. Biochim Biophys Acta 2013, 1831:1322-1334.
27. Tosi M.R., Tugnoli V. Cholesteryl esters in malignancy. Clin Chim Acta 2005, 359:27-45.
28. Nygren C., von Holst H., Mansson J.E., Fredman P. Increased levels of cholesterol esters in glioma tissue and surrounding areas of human brain. Br J Neurosurg 1997, 11:216-220.